MSI Financial Services’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

MSI Financial Services’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4K	Hold	100	–	–	﹤0.01%	3216
2016 Q3	$5K	Hold	100	–	–	﹤0.01%	3115
2016 Q2	$4K	Hold	100	–	–	﹤0.01%	3225
2016 Q1	$4K	Hold	100	–	–	﹤0.01%	3235
2015 Q4	$7K	Buy	+100	New	+$6.68K	﹤0.01%	2890
2014 Q3	–	Sell	-600	Closed	-$28K	–	2638
2014 Q2	$28K	Buy	+600	New	+$23.7K	﹤0.01%	1340

Other funds holding BIB

RIA

RPG Investment Advisory Pleasanton, California $829M AUM 36.68% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

CIC

Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return

BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Timber Hill Greenwich, Connecticut $15.4M AUM 30.7% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

MSI Financial Services's BIB Position: Q4 2016 in Review

MSI Financial Services held its ProShares Ultra NASDAQ Biotechnology (BIB) position steady in Q4 2016 at 100 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #3216.

MSI Financial Services first reported a position in BIB in Q2 2014 and has held it in 6 quarters since. The position peaked at $28K in Q2 2014. 31 funds tracked by Wall St. Rank hold BIB as of Q4 2016.

MSI Financial Services held 100 shares of ProShares Ultra NASDAQ Biotechnology worth $4K as of Q4 2016.
MSI Financial Services left its ProShares Ultra NASDAQ Biotechnology share count unchanged in Q4 2016.
ProShares Ultra NASDAQ Biotechnology made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3216 holding.
MSI Financial Services first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2014 and has held it in 6 quarters since.
MSI Financial Services's ProShares Ultra NASDAQ Biotechnology position peaked at $28K in Q2 2014.
31 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.